Current News Releases

Healthy Heart

When it comes to your heart health, it’s never too early or too late to start making meaningful changes to your lifestyle. Not only is it important to eat right and move more, but also to know your risks for certain heart diseases and understand your numbers. From learning the best diets for your heart to smart approaches to exercise, our experts provide guidance on keeping your heart in tip-top shape.

Tip Sheet: Johns Hopkins Researchers Present Findings at Science Conference in Seattle

What: The Annual Conference on Retroviruses and Opportunistic Infections

When: Feb. 13–16, 2017

Where: Seattle, Washington, Washington State Convention Center

(705 Pike St., Seattle, WA 98101)

Johns Hopkins Kimmel Cancer Center Names Benjamin Levy to Lead Medical Oncology Program at Sibley

Lung cancer specialist Benjamin Levy, M.D., has been named the new clinical director of medical oncology and medical director of thoracic oncology for the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in northwest Washington, D.C.

An ‘Ignition Key’ Revs Up DNA Shuffling To Make Antibodies

Rearranging the genome is a risky endeavor, and human cells reserve it for special occasions, like making egg and sperm cells. Now, researchers at Johns Hopkins Medicine announce they’ve learned how an enzyme that reshuffles DNA on one of those rare occasions — during the birth of new white blood cells — helps ensure the process doesn’t go haywire. Their results are described online this week in the Proceedings of the National Academy of Sciences.

16 Aplastic Anemia Patients Free Of Disease After Bone Marrow Transplant and Chemo

Physicians at the Johns Hopkins Kimmel Cancer Center report they have successfully treated 16 patients with a rare and lethal form of bone marrow failure called severe aplastic anemia using partially matched bone marrow transplants followed by two high doses of a common chemotherapy drug. In a report on the new transplant-chemo regimen, published online Dec. 22, 2016, in Biology of Blood and Marrow Transplantation, the Johns Hopkins team says that more than a year after their transplants, all of the patients have stopped taking immunosuppressive drugs commonly used to treat the disorder and have no evidence of the disease.

Johns Hopkins Awarded Multimillion-Dollar Contract in Effort to Improve Surgical Outcomes for Patients

The Johns Hopkins Armstrong Institute for Patient Safety and Quality, in collaboration with the American College of Surgeons, has been awarded a nearly $4 million contract, with the option of $12 million over three years, for a total of about $16 million from the Agency for Healthcare Research and Quality (AHRQ) to improve the outcomes and experiences of surgery patients across the United States. The project, funded and guided by AHRQ, will enable more than 750 hospitals to implement enhanced recovery after surgery (ERAS) protocols, which have been shown to reduce complications, decrease lengths of stay and boost patient experience.

Sleep Deprivation Handicaps the Brain’s Ability to Form New Memories, Study in Mice Shows

Studying mice, scientists at Johns Hopkins have fortified evidence that a key purpose of sleep is to recalibrate the brain cells responsible for learning and memory so the animals can “solidify” lessons learned and use them when they awaken — in the case of nocturnal mice, the next evening.

Johns Hopkins Medicine Alliance for Patients Announces Renewed Participation in Medicare Program

The Johns Hopkins Medicine Alliance for Patients (JMAP), the Accountable Care Organization (ACO) of Johns Hopkins Medicine, announces that it has been selected by the Centers for Medicare and Medicaid Services to renew its participation in the Medicare Shared Savings Program for the next three years. The Shared Savings Program offers financial incentives to encourage ACOs to improve coordination, communication and overall care for Medicare fee-for-service beneficiaries while also reducing health care costs.

Study Affirms That Cocaine Makes Users More Likely To Risk Unsafe Sex

Cocaine use has long been tied anecdotally to higher-than-usual rates of impulsive behavior, including risky sex, but the tie-in has been difficult to study with any scientifically controlled rigor.

Targeting Parkinson’s-Linked Protein Could Neutralize 2 of the Disease’s Causes

Researchers report they have discovered how two problem proteins known to cause Parkinson’s disease are chemically linked, suggesting that someday, both could be neutralized by a single drug designed to target the link. A report on their discovery appears in the Jan. 24 issue of Cell Reports.

Virtual Press Conference – The Science of the Super Bowl

Reporters, please join Newswise on Thursday, Feb. 2, at 2 p.m. ET for a live event featuring Johns Hopkins’ Vikram Chib and other experts who will scientifically analyze various aspects of this major pop culture event.

New Year, New You: Tips on Keeping Your Resolutions

Our experts, available for interview, can provide some insight on how to successfully start and maintain a healthy lifestyle, including advice on how to kick off the transition to a healthier you, pick the right diet and select strategies that actually help you keep the promises you’ve made.

Updated Cystic Fibrosis Diagnosis Guidelines Can Help in Diagnosis, Personalized Treatment

An international research group of 32 experts from nine countries has updated the guidelines for diagnosing the genetic disease cystic fibrosis.

Blood Test That Detects Changes in Tumor DNA Predicts Survival of Women with Advanced Breast Cancers

Results of a multicenter study of 129 women with advanced breast cancer show that a blood test that spots cancer-linked DNA correctly predicted that most of those patients with higher levels of the tumor markers died significantly earlier than those with lower levels.

What Can You Do To Have More ‘Face Time’ With Your Doctor? Arrive Early For the Appointment

A study examining doctor and patient behavior at three Johns Hopkins Medicine outpatient clinics has found evidence that clinicians spend more face-to-face time with patients when the clinic is on schedule and less when the clinic is running late.

Media Alert: Caring For the Whole Person: Hands-On Demonstrations Teach Maryland Medical Students the Scope of Physical Medicine and Rehabilitation

The Johns Hopkins University School of Medicine’s Physical Medicine and Rehabilitation Interest Group invites medical students from Maryland and Washington D.C. to the first annual PM&R Expo. This “PM&R 101” event will allow future health care providers to get a taste of the different clinical treatments available within physical medicine and rehabilitation.

Women’s Health Research Presented at National Conference in Las Vegas

What: The Society for Maternal-Fetal Medicine’s 37th annual Pregnancy Meeting
When: Jan. 26–28, 2017
Where: Caesars Palace, Las Vegas, Nevada

Trying to Tango with More Than 2: Extra Centrosomes Promote Tumor Formation in Mice

When a cell is dividing, two identical structures, called centrosomes, move to opposite sides of the cell to help separate its chromosomes into the new cells. More than 100 years ago, scientists observed that cancer cells often have more than two centrosomes, but they couldn’t untangle whether the extra structures were a result of the cancer — or part of its cause. Now, biologists at Johns Hopkins have solved that conundrum, finding that extra centrosomes can single-handedly promote tumor formation in mice.

Baltimore Youth Have Limited Access to HIV Testing in Nonclinical Community Settings, New Study Finds

A new survey of 51 youth-serving, nonclinical, community-based organizations in Baltimore, Maryland, found that the majority did not offer HIV testing, nor did they have established links to refer youth to testing. Organizations that did provide HIV tests were more likely to offer general health services and referral services for sexually transmitted infections screening outside of HIV, and had staff members who were more comfortable talking about sexual health issues.

New Peptide Could Improve Treatment for Vision-Threatening Disease

Johns Hopkins researchers report that a new peptide holds promise for improving treatment for degenerative retinal diseases, such as age-related macular degeneration, diabetic macular edema and diabetic retinopathy. These vascular diseases often result in central vision loss as blood vessels grow into tissues at the back of the eye, where such growth should not occur.